I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?
Frederik A VerburgLuca GiovanellaIoannis IakovouMark W KonijnenbergWerner LangstegerMichael LassmannJasna MihailovicMarkus LusterPublished in: European journal of nuclear medicine and molecular imaging (2018)